PRESS RELEASE published on 04/21/2026 at 15:09, 5 months 6 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research reaffirms Buy rating for MaaT Pharma SACA with a target price of €17 following FY25 results and pipeline update. No changes to core investment case First Berlin Equity Research BUY Rating MaaT Pharma SACA FY25 Results €17 Target Price
BRIEF published on 04/01/2026 at 07:35, 5 months 26 days ago MaaT Pharma Presents CHRONOS Study Results on Third-Line Acute GvHD MaaT Pharma Regulatory Review CHRONOS Study Acute GvHD Third-line Therapy
BRIEF published on 04/01/2026 at 07:35, 5 months 26 days ago MaaT Pharma publishes data on aGvH in "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
BRIEF published on 04/01/2026 at 07:35, 5 months 26 days ago MaaT Pharma publie des données sur l'aGvH dans "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
BRIEF published on 04/01/2026 at 07:35, 5 months 26 days ago MaaT Pharma présente les résultats de l'étude CHRONOS sur le traitement de troisième ligne de la GVHD aiguë MaaT Pharma Examen Réglementaire Étude CHRONOS GVHD Aiguë Traitement De Troisième Ligne
PRESS RELEASE published on 04/01/2026 at 07:30, 5 months 26 days ago Inside Information / Other news releases MaaT Pharma announces publication of retrospective data from CHRONOS study in Bone Marrow Transplantation Journal, presenting real-world outcomes of third-line systemic treatments for GI-aGvHD patients MaaT Pharma GI-aGvHD CHRONOS Study Retrospective Data Bone Marrow Transplantation
PRESS RELEASE published on 04/01/2026 at 07:30, 5 months 26 days ago Informations privilégiées / Autres communiqués MaaT Pharma publie des données rétrospectives de l'étude CHRONOS sur la maladie aiguë du greffon contre l'hôte (aGvH) dans Bone Marrow Transplantation. Résultats présentés au congrès annuel 2026 de l'EBMT MaaT Pharma Étude Bone Marrow Transplantation CHRONOS Maladie Aiguë Du Greffon Contre L'hôte
BRIEF published on 03/31/2026 at 07:35, 5 months 27 days ago MaaT Pharma: 2025 Revenue and Clinical Progress Revenue Funding Clinical Development MaaT Pharma Microbiothérapies
BRIEF published on 03/31/2026 at 07:35, 5 months 27 days ago MaaT Pharma : Chiffre d'Affaires 2025 et Progrès Cliniques Chiffre D'affaires Financement Développement Clinique MaaT Pharma Microbiothérapies
PRESS RELEASE published on 03/31/2026 at 07:30, 5 months 27 days ago Informations privilégiées / Information sur chiffre d’affaires annuel MaaT Pharma annonce ses résultats annuels pour l'année 2025 et fait le point sur ses activités. Avancées MaaT013, pipeline MaaT033 et MaaT034, accord de financement, trésorerie et perspectives de développement Développement Résultats Annuels Pipeline MaaT Pharma Accord Financement
Published on 09/26/2026 at 01:00, 1 day 21 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 23 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 4 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 7 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 5 hours 1 minute ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 6 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 6 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 6 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 14 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 4 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 4 hours ago Availability of the 2026 half-year financial report
